Skip to main content
. 2014 May 16;14(2):147–154. doi: 10.1007/s40268-014-0046-8

Fig. 3.

Fig. 3

Therapeutic profile before (baseline) and after adding lercanidipine/enalapril 10/20 mg fixed-dose combination. ACEI angiotensin-converting enzyme inhibitor, ARAII angiotensin II receptor antagonist, CCB calcium channel blocker, FDC fixed-dose combination, RI renin inhibitor